Abstract:Objective: Colorectal cancer (CRC) is the third cause of expected cancer deaths both in men and women in the U.S. and the third most commonly diagnosed cancer in China Targeted therapy has been proven to improve overall survival for unresectable metastatic CRC. But the location of the primary tumor or the presence of various core driver gene mutations that confer resistance may limit the utility of targeted therapy. Therefore, it is of great significance to further elucidate novel mechanisms of invasion and metastasis of CRC and find potential novel therapeutic targets. Protein Kinase C Delta (PKC delta) plays an important role in various diseases, including tumors. In CRC, the function of PKC delta on proliferation and differentiation is mostly studied but various research results were reported. Therefore, the role of PKC delta in CRC needs to be further studied, especially in tumor invasion and metastasis in CRC which few studies have looked into.Methods: The expression of PRKCD was analyzed by the Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases and Immunohistochemical (IHC). Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) enrichment analysis were used to explore the biological functions and pathways related to PRKCD. Lentivirus transfection was used to construct CRC cell lines with overexpression and knock-down of PKC delta or N-myc Downstream Regulated Gene 1 (NDRG1). Cell invasion and migration assay, wound healing assay were used to detect the function of PKC delta and NDRG1 in the invasion and migration of cells. Flow cytometry analysis was used to detect the influence of PKC delta on the CRC cell cycles .Immunofluorescence histochemistry ,Immunoprecipitation Assay and qPCR were used to detect the relationship of PKC delta and NDRG1. Xenograft model was used to verify the role of PKC delta in vivo.Results: PKC delta is overexpressed in CRC and could promote Epithelial-Mesenchymal Transition (EMT) and the invasion and migration of CRC in vitro. We confirmed that PKC delta and the tumor suppressor factor NDRG1 had a co-localization relationship in CRC. PKC delta inhibited NDRG1 transcription and protein expression. Overexpressing NDRG1 could inhibit the function of PKC delta in promoting tumor invasion and migration. PKC delta could regulate c-Myc, one transcription factor of NDRG1, to down-regulate NDRG1. In vivo, overexpressing PKC delta could promote xenograft growth and volume. Thus, our results showed that PKC delta reduced the expression of NDRG1 through c-Myc, promoting the invasion and migration of CRC through promoting EMT.Conclusion: The increased expression of PKC delta in CRC tumor tissue could promote the invasion and migration of tumor cells, and one of the mechanisms may be regulating c-Myc to inhibit the expression of NDRG1 and promote EMT.

Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway

Keratin 80 Promotes Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating the TGF-β/SMAD Pathway

KRT80 Promotes Lung Adenocarcinoma Progression and Serves as a Substrate for VCP

The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer

PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway

PKC delta promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway

Characters of KRT80 and its roles in neoplasms diseases

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer

PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer

Kallikrein-related peptidase 10 predicts prognosis and mediates tumor immunomodulation in colorectal cancer

Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes

Keratin17 Promotes Tumor Growth and is Associated with Poor Prognosis in Gastric Cancer

KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1

KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway

KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer via PI3K/AKT/mTOR Signaling Pathway

KIF15 Knockdown Inhibits Colorectal Cancer Proliferation and Migration Through Affecting the Ubiquitination Modification of NRAS.

KRT17 Promotes T-lymphocyte Infiltration Through the YTHDF2-CXCL10 Axis in Colorectal Cancer

KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer <i>via</i> PI3K/AKT/mTOR Signaling Pathway

DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer

PRKCB is a novel and potential biomarker in colon cancer and shapes an inflamed tumor immune microenvironment